In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
Q&AChina CDE Q&A | Biologics' R&D, Associated Review of APIs, Excipients, and Packaging Materials, Requirements for Changes, and More
Sep 05, 2022
Q&AChina CDE Q&A | BE Study, Reference Listed Drug, and Quality & Therapeutic Equivalence Evaluation
Aug 30, 2022
REPORT2021 China CDE Drug Evaluation Report
Jul 04, 2022
INTERPRETATIONDrug Application Fees for FY 2022 in China and the U.S.
Feb 11, 2022
INTERPRETATIONChina Drug Master File (DMF) Filing for APIs, Pharmaceutical Excipients & Packaging Materials
May 07, 2021
REPORTSelection of 2019 China Center for Drug Evaluation Annual Report
Mar 08, 2021